[1]
De Marco, G., Gerloni, V., Pontikaki, I., Lurati, A., Teruzzi, B., Salmaso, A., Valcamonica, E., Gattinara, M. and Fantini, F. 2007. Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy. Reumatismo. 59, 1 (Mar. 2007), 50–56. DOI:https://doi.org/10.4081/reumatismo.2007.50.